Literature DB >> 26356735

Methods in HPV Surveillance: Experiences from a Population-Based Study of HPV Infection among Women in the San Juan Metropolitan Area of Puerto Rico.

Ana Patricia Ortiz1, Edmir Marrero1, Cristina Muñoz1, Cynthia M Pérez2, Guillermo Tortolero-Luna3, Josefina Romaguera4, Nahir Rodríguez2, Andrea González-Falero5, Joel Palefsky6, Erick Suárez2.   

Abstract

This article describes the methodology of the first population-based study of human papillomavirus (HPV) infection among women aged 16-64 years residing in the San Juan Metropolitan Area of Puerto Rico (PR). The sample was identified through a complex sampling design of households. The sampling frame was selected in four stages, using census tracts maps from the Census Bureau. Women completed a face-to-face interview and a computer-assisted self-interview using the Audio CASI system, for the collection of demographic, clinical, and lifestyle variables, and sampling acceptability. Anal, cervical, and oral specimens were collected through self-collection methods for HPV DNA testing using a modified pool of MY09/MY11 consensus HPV L1 and human ß-globin amplification primers. Anthropometric measurements were taken using the Third National Health and Nutrition Examination Survey methodology. Blood samples were collected to create a bio-repository for future HPV-related studies. Fifty census tract blocks were randomly selected. We recruited 566 women, with a response rate of 83.4%. Response rates did not vary by age-group (p>0.05); although they varied by socioeconomic (SES) census block stratums (p<0.05), response rates were good (>75%) in all SES strata. All participants agreed to respond to the surveys and provide the requested anogenital and oral samples. Overall, more than 98% understood and more than 50% felt comfortable with the cervical, anal, and oral self-collection methods used. This article documents the feasibility of performing population-based studies for HPV surveillance in women in PR.

Entities:  

Keywords:  HPV; Infection; Methods; Puerto Rico; Women

Mesh:

Substances:

Year:  2015        PMID: 26356735

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  6 in total

1.  Factors Associated with HPV Vaccine Awareness in a Population-Based Sample of Hispanic Women in Puerto Rico.

Authors:  J Romaguera; D Caballero-Varona; G Tortolero-Luna; E Marrero; E Suárez; C M Pérez; C Muñoz; J Palefsky; A P Ortiz
Journal:  J Racial Ethn Health Disparities       Date:  2015-07-14

2.  Chlamydia Trachomatis and Human Papillomavirus Serostatus in Puerto Rican Women.

Authors:  Maira A Castañeda-Avila; Erick Suárez-Pérez; Raúl Bernabe-Dones; Elizabeth R Unger; Gitika Panicker; Ana P Ortiz
Journal:  P R Health Sci J       Date:  2020-03       Impact factor: 0.705

3.  Same-Sex Behavior and its Relationship with Sexual and Health-Related Practices Among a Population-Based Sample of Women in Puerto Rico: Implications for Cancer Prevention and Control.

Authors:  Marievelisse Soto-Salgado; Vivian Colón-López; Cynthia Perez; Cristina Muñoz-Masso; Edmir Marrero; Erick Suárez; Ana P Ortiz
Journal:  Int J Sex Health       Date:  2016-08-22

4.  Sex Differences in Risk Factors for Oral and Pharyngeal Cancer among Puerto Rican Adults.

Authors:  Maira Castañeda-Avila; Cynthia M Pérez; José Vivaldi; Elba C Díaz-Toro; Hilmaris Centeno; Ana Patricia Ortiz
Journal:  J Health Dispar Res Pract       Date:  2020

5.  Prevalence, genotyping, and correlates of anogenital HPV infection in a population-based sample of women in Puerto Rico.

Authors:  A P Ortiz; J Romaguera; C M Pérez; D González; C Muñoz; L González; E Marrero; G Tortolero-Luna; E Suárez; J Palefsky
Journal:  Papillomavirus Res       Date:  2016-04-26

6.  Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16-64 years in Puerto Rico.

Authors:  A P Ortiz; G Tortolero-Luna; J Romaguera; C M Pérez; D González; C Muñoz; L González; E Marrero; E Suárez; J M Palefsky; G Panicker; E R Unger
Journal:  Papillomavirus Res       Date:  2018-03-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.